IT1164029B - Composizioni farmaceutiche solide a base di alcaloidi della segale cornuta,che permettono una liberazione controllata di questo principio attivo - Google Patents

Composizioni farmaceutiche solide a base di alcaloidi della segale cornuta,che permettono una liberazione controllata di questo principio attivo

Info

Publication number
IT1164029B
IT1164029B IT51153/79A IT5115379A IT1164029B IT 1164029 B IT1164029 B IT 1164029B IT 51153/79 A IT51153/79 A IT 51153/79A IT 5115379 A IT5115379 A IT 5115379A IT 1164029 B IT1164029 B IT 1164029B
Authority
IT
Italy
Prior art keywords
alcaloids
allow
active ingredient
pharmaceutical compositions
solid pharmaceutical
Prior art date
Application number
IT51153/79A
Other languages
English (en)
Italian (it)
Other versions
IT7951153A0 (it
Inventor
Franz Joachim
Ludwig Patt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT7951153A0 publication Critical patent/IT7951153A0/it
Application granted granted Critical
Publication of IT1164029B publication Critical patent/IT1164029B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT51153/79A 1978-12-21 1979-12-20 Composizioni farmaceutiche solide a base di alcaloidi della segale cornuta,che permettono una liberazione controllata di questo principio attivo IT1164029B (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1302178 1978-12-21
CH1301978 1978-12-21
CH56779 1979-01-19
CH56679 1979-01-19

Publications (2)

Publication Number Publication Date
IT7951153A0 IT7951153A0 (it) 1979-12-20
IT1164029B true IT1164029B (it) 1987-04-08

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51153/79A IT1164029B (it) 1978-12-21 1979-12-20 Composizioni farmaceutiche solide a base di alcaloidi della segale cornuta,che permettono una liberazione controllata di questo principio attivo

Country Status (23)

Country Link
AT (1) AT372279B (Direct)
AU (1) AU534051B2 (Direct)
CA (1) CA1139222A (Direct)
CH (1) CH642259A5 (Direct)
CY (1) CY1330A (Direct)
DE (1) DE2950154A1 (Direct)
DK (1) DK154607C (Direct)
FI (1) FI793888A7 (Direct)
FR (1) FR2444463A1 (Direct)
GB (1) GB2038181B (Direct)
HK (1) HK37986A (Direct)
HU (1) HU182577B (Direct)
IE (1) IE49323B1 (Direct)
IL (1) IL59003A (Direct)
IT (1) IT1164029B (Direct)
KE (1) KE3617D (Direct)
MY (1) MY8500129A (Direct)
NL (1) NL187229C (Direct)
NZ (1) NZ192457A (Direct)
PH (1) PH25178A (Direct)
PT (1) PT70614A (Direct)
SE (1) SE442265B (Direct)
WO (1) WO1980001242A1 (Direct)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Also Published As

Publication number Publication date
CH642259A5 (de) 1984-04-13
CA1139222A (en) 1983-01-11
IT7951153A0 (it) 1979-12-20
DE2950154A1 (de) 1980-07-10
FR2444463A1 (fr) 1980-07-18
MY8500129A (en) 1985-12-31
DK529879A (da) 1980-06-22
ATA803679A (de) 1983-02-15
IL59003A (en) 1982-12-31
IE792471L (en) 1980-06-21
IE49323B1 (en) 1985-09-18
NL7909105A (nl) 1980-06-24
FI793888A7 (fi) 1981-01-01
SE7910227L (sv) 1980-06-22
AT372279B (de) 1983-09-26
HK37986A (en) 1986-05-30
SE442265B (sv) 1985-12-16
DE2950154C2 (Direct) 1989-05-11
CY1330A (en) 1986-06-27
GB2038181A (en) 1980-07-23
DK154607C (da) 1989-06-05
NL187229C (nl) 1991-07-16
KE3617D (en) 1986-04-18
PH25178A (en) 1991-03-27
HU182577B (en) 1984-02-28
AU534051B2 (en) 1984-01-05
DK154607B (da) 1988-12-05
AU5403179A (en) 1980-06-26
PT70614A (fr) 1980-01-01
WO1980001242A1 (fr) 1980-06-26
FR2444463B1 (Direct) 1983-02-25
NZ192457A (en) 1983-06-17
GB2038181B (en) 1983-05-11

Similar Documents

Publication Publication Date Title
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
IT1066085B (it) Composizione farmaceutica antinfiammatoria a base di corticosteroidi,particolarmente per il trattamento di manifestazioni infiammatorie di dermatosi,e procedimento per la sua preparazione
BE872319A (fr) Composition pharmaceutique
IT1070839B (it) Composto farmacologicamente attivi
PT65949A (pt) Pharmacologically active compounds
IT1152489B (it) Alcaloidi peptidici della segale cornuta,loro preparazione e composizioni farmaceutiche che li contengono
FR2600253B1 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene
IT1209454B (it) Composizione farmaceutica a base di estratti di mirtillo.
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
IT7949884A0 (it) Composti retinoidi e composizioni farmaceutiche ad azione anti-carcinogenica che li contengono
AR216744A1 (es) Nuevos derivados de la fenil-3-oxadiazolina-1,3,4-ona-2,particularmente utiles como agentes activos insecticidas,acaricidas y nematocidas,procedimiento para la preparacion de dichos derivados,composiciones insecticidas,acaricidas y nematocidas que contienen a dichos nuevos derivados
NL7600906A (nl) Farmacologisch actieve verbindingen.
BE826935A (fr) Compositions pharmaceutiques antivirales
BE857122A (fr) Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active
BE873481A (fr) Nouvelles compositions pharmaceutiques a base de prostaglandines
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
IT1141608B (it) Derivati della & metilen azetidina particolarmente utili come medicamenti
IT7951153A0 (it) Composizioni farmaceutiche solide abase di alcaloidi della segale cornuta, che permettono una liberazione controllata di questo principio attivo
IT1191255B (it) Composizione farmaceutiche a base di alcaloidi della segale cornuta 9,10-diidrogenati
IT7823915A0 (it) Analoghi della prostaglandina e1 e composizioni farmaceutiche che licontengono.
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
NL7613093A (nl) Farmacologisch actieve verbindingen.
NL7801464A (nl) Farmaceutische samenstellingen.
BE849872A (fr) Compositions pharmaceutiques anti-inflammatoires
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.